[1] 孙秀英, 季海生, 朱德全.骨与关节化脓性感染的临床与实验室分析[J].医学检验与临床, 2006, 17(1):48-50.
[2] Clinical Laboratory Standards Institue(CLSI).Performance standards for Antimicrobial Susceptibility testing;twentieth Informational Supplement[S].M100-S20.CLSI, 2006:100.
[3] 彭文伟.现代感染性疾病与传染病学[M].北京:科学出版社, 2000:250-259.
[4] Montanaro L, Speziale P, Campoccia D, et al.Scenery of Staphylococcus implant infections in orthopedics[J].Future Microbiol, 2011, 6(11):1329-1349.
[5] Spellberg B, Lipsky BA.Systemic antibiotic therapy for chronic osteomyelitis in adults[J].Clin Infect Dis, 2012, 54(3):393-407.
[6] Achermann Y, Eigenmann K, Ledergerber B, et al.Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections(PJI):a matched case-control study[J].Infection, 2013, 41(2):431-437.
[7] Campoccia D, Montanaro L, Speziale P, et al.Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use[J].Biomaterials, 2010, 31(25):6363-6377.
[8] Yu F, Liu H, Li KH, et al.Causative organisms and their antibiotic resistance patterns for childhood septic arthritis in china between 1989 and 2008[J].Orthopedics, 2011, 34(3):179.
[9] Schmieder R, Edwards R.Insights into antibiotic resistance through metagenomic approaches[J].Future Microbiol, 2011, 7(1):73-89.